EcoDrugPlus

Erb-B2 Receptor Tyrosine Kinase 4a

Ensembl ID : ENSCHAG00000009363
Gene Symbol: ERBB4A
1 Cross references
243 Possible Orthologues:

Estrogen Receptor 2a

Ensembl ID : ENSCHAG00000014970
Gene Symbol: ESR2A
1 Cross references
200 Possible Orthologues:

Estrogen-Related Receptor Gamma A

Ensembl ID : ENSCHAG00000009230
Gene Symbol: ESRRGA
1 Cross references
201 Possible Orthologues:

Exportin 1

Ensembl ID : ENSCHAG00000002294
Gene Symbol: XPO1
1 Cross references
156 Possible Orthologues:

Exportin 1

Ensembl ID : ENSCHAG00000008476
Gene Symbol: XPO1
1 Cross references
229 Possible Orthologues:

Farnesyl Diphosphate Synthase

Ensembl ID : ENSCHAG00000009413
Gene Symbol: FDPS
3 Cross references
269 Possible Orthologues:

Farnesyl-Diphosphate Farnesyltransferase 1

Ensembl ID : ENSCHAG00000002577
Gene Symbol: FDFT1
1 Cross references
221 Possible Orthologues:

Farnesyltransferase, Caax Box, Alpha

Ensembl ID : ENSCHAG00000003134
Gene Symbol: FNTA
1 Cross references
222 Possible Orthologues:

Farnesyltransferase, Caax Box, Beta

Ensembl ID : ENSCHAG00000007564
Gene Symbol: FNTB
1 Cross references
159 Possible Orthologues:

Farnesyltransferase, Caax Box, Beta

Ensembl ID : ENSCHAG00000019785
Gene Symbol: FNTB
3 Cross references
186 Possible Orthologues:

Fibroblast Growth Factor Receptor 1

Ensembl ID : ENSCHAG00000016543
Gene Symbol: FGFR1
1 Cross references
201 Possible Orthologues:

Fibroblast Growth Factor Receptor 1b

Ensembl ID : ENSCHAG00000022788
Gene Symbol: FGFR1B
1 Cross references
209 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).